The ARRISA-UK Study
At-Risk Registers Integrated into primary care to Stop Asthma crises in the UK
Information for GP Practices considering participation in ARISSA-UK
Information to Review
Please find below useful documents about the study - Where applicable, please click on your region
- A short summary
- A Research Information Sheet for Practices (RISP) form: Eastern, England and Wales, Scotland. For region specific RISP please contact the study office.
- The Practice information sheet.
- A Timeline of the study's activities and data collection as they occur in each participating practice.
- Assurance Letters:
- England (pre-HRA): Eastern, Kent, Wessex
- Scotland: Lothian, Grampian, Greater Glasgow and Clyde, Lanarkshire, Tayside
- Wales: Abertawe Bro Morgannwg University HB, Aneurin Bevan HB, Betsi Cadwaladr University HB, Cardiff & Vale University HB, Cwm Taf HB, Hywel Dda HB, Powys Teaching HB
- The HRA Approval letter and local assurance documents where applicable: North Thames, Surrey Sussex, Nottingham City, Nottingham County CCGs, Lincolnshire CCGs, South West Peninsula, North East and North Cumbria, North West Coast, Bristol, North Somerset and South Gloucestershire CCGs, Bath & NE Somerset, Swindon and Wiltshire CCGs, Gloucestershire CCG.
Interested to participate in the study? Signing up is just 2-3 simple steps
Please complete and return the following essential documents:
1a. ONLY For Eastern region: The practice agreement form on the last page of the RISP, which is to be sent to the Research Network Office (see link above)
1b. All Regions. Please complete the ARRISA-UK Practice Survey: This is available as an online form at the Norwich Clinical Trials Unit website (works best with Internet Explorer 9 onward, Chrome, Mozilla Firefox or on an iOS device) or as either a Word or PDF document to download, fill, and email or post to us. To fill the online form you will need to know your practice's NHS ID (which looks like: "D12345"; if you are uncertain about yours, call us and we can tell it to you.)
Once we've received your completed survey, we will contact you to confirm your eligibility
2. Study Agreements:
- Site Agreement (a mini-contract with UEA - a Word document): Eastern, Kent Surrey Sussex, South West Peninsula, North Thames, Wessex, Nottingham City, Nottinghamshire, Lincolnshire, Scotland and Wales.
- Data Service Agreement: For VISION and SystmOne practices please sign the following OPC Agreements. For EMIS practices please sign the following OPC Agreements.
Please do not hesitate to contact us if you have any questions about the study or these documents.
We will then contact you to discuss further details, answer any questions and give you a schedule for the next steps.
Is your practice eligible?
Almost all GP practices in the UK ARE eligible. (Practices using Microtest Evolution will not be able to have anonymous data extraction via Optimum Patient Care (OPC) and thus cannot participate)
However, the list below represents the exclusion criteria:
- Practices already implementing a formal prospective process of identification of patients with at-risk asthma AND practice wide targeting of asthma care on every approach to patient or their record.
- Practices hosting or affected by research which might significantly influence the practice wide process of care of patients with ‘at risk’ asthma.
If your practice was an intervention practice in previous ARRISA research, please contact the study office.
Alternatively, a document detailing practice eligibility can be found here.
Contact for any questions.
Please contact the study office on 01603 593309 if you have any questions regarding practice eligibility or the use of any of the documents on this page.